Jagged2-signaling promotes IL-6-dependent transplant rejection

European Journal of Immunology

Volumn 43, Issue 6, 2013, Pages 1449-1458

  Riella, Leonardo V ^a,b   Yang, Jun ^a   Chock, Susanne ^a   Safa, Kassem ^a   Magee, Ciara N ^a   Vanguri, Vijay ^c   Elyaman, Wassim ^a   Lahoud, Youmna ^a   Yagita, Hideo ^d   Abdi, Reza ^a   Najafian, Nader ^a   Medina Pestana, José O ^b   Chandraker, Anil ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Mice; Notch signaling; Regulatory T (Treg) cells; Rejection; Transplantation

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; JAGGED2 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MP 5 20F3; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; TH2 CELL; UPREGULATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CELLS, CULTURED; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; INTERLEUKIN-6; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84879496417     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243151     Document Type: Article

References (61)

1. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007. 25: 821-852.
2. Kapsenberg, M. L., Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
3. Osborne, B. A. and Minter, L. M., Notch signalling during peripheral T-cell activation and differentiation. Nat. Rev. Immunol. 2007. 7: 64-75.
4. Amsen, D., Blander, J. M., Lee, G. R., Tanigaki, K., Honjo, T. and Flavell, R. A., Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004. 117: 515-526.
5. Maillard, I., Fang, T. and Pear, W. S., Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 2005. 23: 945-974.
6. Yuan, J. S., Kousis, P. C., Suliman, S., Visan, I. and Guidos, C. J., Functions of notch signaling in the immune system: consensus and controversies. Annu. Rev. Immunol. 2010. 28: 343-365.
7. Radtke, F., Fasnacht, N. and Macdonald, H. R., Notch signaling in the immune system. Immunity 2010. 32: 14-27.
8. Yamaguchi, E., Chiba, S., Kumano, K., Kunisato, A., Takahashi, T. and Hirai, H., Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice. Immunol. Lett. 2002. 81: 59-64.
9. Kubo, M., Notch: filling a hole in T helper 2 cell differentiation. Immunity 2007. 27: 3-5.
10. Houde, C., Li, Y., Song, L., Barton, K., Zhang, Q., Godwin, J., Nand, S. et al., Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 2004. 104: 3697-3704.
11. Fang, T. C., Yashiro-Ohtani, Y., Del Bianco, C., Knoblock, D. M., Blacklow, S. C. and Pear, W. S., Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 2007. 27: 100-110.
12. Krishnamoorthy, N., Oriss, T. B., Paglia, M., Fei, M., Yarlagadda, M., Vanhaesebroeck, B., Ray, A. et al., Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 2008. 14: 565-573.
13. Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H. R. and Aguet, M., Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999. 10: 547-558.
14. Tanigaki, K. and Honjo, T., Regulation of lymphocyte development by Notch signaling. Nat. Immunol. 2007. 8: 451-456.
15. Amsen, D., Antov, A. and Flavell, R. A., The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 2009. 9: 116-124.
16. Riella, L. V., Ueno, T., Batal, I., De Serres, S. A., Bassil, R., Elyaman, W., Yagita, H. et al., Blockade of Notch ligand Delta1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation. J. Immunol. 2011. 187: 4629-4638.
17. Elyaman, W., Bassil, R., Bradshaw, E. M., Orent, W., Lahoud, Y., Zhu, B., Radtke, F. et al., Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 2012. 36: 623-634.
18. Schenk, S., Kish, D. D., He, C., El-Sawy, T., Chiffoleau, E., Chen, C., Wu, Z. et al., Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J. Immunol. 2005. 174: 3741-3748.
19. Yang, J., Popoola, J., Khandwala, S., Vadivel, N., Vanguri, V., Yuan, X., Dada, S. et al., Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008. 117: 660-669.
20. Yang, J., Riella, L. V., Boenisch, O., Popoola, J., Robles, S., Watanabe, T., Vanguri, V. et al., Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am. J. Transplant. 2009. 9: 2837-2844.
21. Riella, L. V., Liu, T., Yang, J., Chock, S., Shimizu, T., Mfarrej, B., Batal, I. et al., Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am. J. Transplant. 2012. 12: 846-855.
22. Kijima, M., Yamaguchi, T., Ishifune, C., Maekawa, Y., Koyanagi, A., Yagita, H., Chiba, S. et al., Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc. Natl. Acad. Sci. USA 2008. 105: 7010-7015.
23. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
24. Pasare, C. and Medzhitov, R., Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
25. Zhao, X., Boenisch, O., Yeung, M., Mfarrej, B., Yang, S., Turka, L. A., Sayegh, M. H. et al., Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am. J. Transplant. 2012. 12: 90-101.
26. Maekawa, Y., Tsukumo, S., Chiba, S., Hirai, H., Hayashi, Y., Okada, H., Kishihara, K. et al., Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003. 19: 549-559.
27. Kaisho, T., Hoshino, K., Iwabe, T., Takeuchi, O., Yasui, T. and Akira, S., Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 2002. 14: 695-700.
28. Krawczyk, C. M., Sun, J. and Pearce, E. J., Th2 differentiation is unaffected by Jagged2 expression on dendritic cells. J. Immunol. 2008. 180: 7931-7937.
29. Tu, L., Fang, T. C., Artis, D., Shestova, O., Pross, S. E., Maillard, I. and Pear, W. S., Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 2005. 202: 1037-1042.
30. Moriyama, Y., Sekine, C., Koyanagi, A., Koyama, N., Ogata, H., Chiba, S., Hirose, S. et al., Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. Int. Immunol. 2008. 20: 763-773.
31. Worsley, A. G., LeibundGut-Landmann, S., Slack, E., Phng, L. K., Gerhardt, H., Reis e Sousa, C. and MacDonald, A. S., Dendritic cell expression of the Notch ligand Jagged2 is not essential for Th2 response induction in vivo. Eur. J. Immunol. 2008. 38: 1043-1049.
32. Elyaman, W., Bradshaw, E. M., Wang, Y., Oukka, M., Kivisakk, P., Chiba, S., Yagita, H. et al., JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 5990-5998.
33. Ong, C. T., Sedy, J. R., Murphy, K. M. and Kopan, R., Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS One 2008. 3: e2823.
34. Amsen, D., Antov, A., Jankovic, D., Sher, A., Radtke, F., Souabni, A., Busslinger, M. et al., Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007. 27: 89-99.
35. Amsen, D., Spilianakis, C. G. and Flavell, R. A., How are T(H)1 and T(H)2 effector cells made? Curr. Opin. Immunol. 2009. 21: 153-160.
36. Tanaka, S., Tsukada, J., Suzuki, W., Hayashi, K., Tanigaki, K., Tsuji, M., Inoue, H. et al., The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 2006. 24: 689-701.
37. Fiorentino, D. F., Bond, M. W. and Mosmann, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 2081-2095.
38. Waaga, A. M., Gasser, M., Kist-van Holthe, J. E., Najafian, N., Muller, A., Vella, J. P., Womer, K. L. et al., Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J. Clin. Invest. 2001. 107: 909-916.
39. + cells, and the alloreactive T cell clone size. J. Immunol. 2002. 169: 3744-3751.
40. Waaga-Gasser, A. M., Grimm, M. R., Lutz, J., Lange, V., Lenhard, S. M., Aviles, B., Kist-van Holthe, J. E. et al., Regulatory allospecific T cell clones abrogate chronic allograft rejection. J. Am. Soc. Nephrol. 2009. 20: 820-830.
41. Shirwan, H., Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 1999. 68: 715-726.
42. Li, X. C., Zand, M. S., Li, Y., Zheng, X. X. and Strom, T. B., On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J. Immunol. 1998. 161: 2241-2247.
43. Illigens, B. M., Yamada, A., Anosova, N., Dong, V. M., Sayegh, M. H. and Benichou, G., Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur. J. Immunol. 2009. 39: 3000-3009.
44. Joffre, O., Santolaria, T., Calise, D., Al Saati, T., Hudrisier, D., Romagnoli, P. and van Meerwijk, J. P., Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 2008. 14: 88-92.
45. Wood, K. J. and Sakaguchi, S., Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 199-210.
46. Kared, H., Adle-Biassette, H., Fois, E., Masson, A., Bach, J. F., Chatenoud, L., Schneider, E. et al., Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity 2006. 25: 823-834.
47. + T cells in autoimmune diabetes. Nat. Immunol. 2001. 2: 1117-1125.
48. Muthukumar, T., Dadhania, D., Ding, R., Snopkowski, C., Naqvi, R., Lee, J. B., Hartono, C. et al., Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 2005. 353: 2342-2351.
49. Diaz, J. A., Booth, A. J., Lu, G., Wood, S. C., Pinsky, D. J. and Bishop, D. K., Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am. J. Transplant. 2009. 9: 1773-1783.
50. Chen, L., Ahmed, E., Wang, T., Wang, Y., Ochando, J., Chong, A. S. and Alegre, M. L., TLR signals promote IL-6/IL-17-dependent transplant rejection. J. Immunol. 2009. 182: 6217-6225.
51. Wan, S., Xia, C. and Morel, L., IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J. Immunol. 2007. 178: 271-279.
52. Yuan, X., Paez-Cortez, J., Schmitt-Knosalla, I., D'Addio, F., Mfarrej, B., Donnarumma, M., Habicht, A. et al., A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 2008. 205: 3133-3144.
53. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009. 27: 485-517.
54. Palmieri, M., Sasso, M. P., Monese, R., Merola, M., Faggioli, L., Tovey, M. and Furia, A., Interaction of the nuclear protein CBF1 with the kappaB site of the IL-6 gene promoter. Nucleic Acids Res. 1999. 27: 2785-2791.
55. Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E. P., Reid, S. P. et al., Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009. 182: 259-273.
56. Samanta, A., Li, B., Song, X., Bembas, K., Zhang, G., Katsumata, M., Saouaf, S. J. et al., TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl. Acad. Sci. USA 2008. 105: 14023-14027.
57. Dienz, O. and Rincon, M., The effects of IL-6 on CD4 T cell responses. Clin. Immunol. 2009. 130: 27-33.
58. Corry, R. J., Winn, H. J. and Russell, P. S., Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973. 16: 343-350.
59. Billingham, M. E., Cary, N. R., Hammond, M. E., Kemnitz, J., Marboe, C., McCallister, H. A., Snovar, D. C. et al., A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 1990. 9: 587-593.
60. Harada, H., Salama, A. D., Sho, M., Izawa, A., Sandner, S. E., Ito, T., Akiba, H. et al., The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J. Clin. Invest. 2003. 112: 234-243.
61. Shimizu, K., Schonbeck, U., Mach, F., Libby, P. and Mitchell, R. N., Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J. Immunol. 2000. 165: 3506-3518.